The impact of the COVID-19 pandemic on cardiovascular disease prevention and management

Caroline E Dale, Rohan Takhar, Raymond Carragher, Michalis Katsoulis, Fatemeh Torabi, Stephen Duffield, Seamus Kent, Tanja Mueller, Amanj Kurdi, Stuart McTaggart, Hoda Abbasizanjani, Sam Hollings, Andrew Scourfield, Ronan Lyons, Rowena Griffiths, Jane Lyons, Gareth Davies, Daniel Harris, Alex Handy, Mehrdad Alizadeh Mizani, Chris Tomlinson, Johan Thygesen, Mark Ashworth, Spiros Denaxas, Amitava Banerjee, Jonathan Sterne, Paul Brown, Ian Bullard, Rouven Priedon, Mamas A Mamas, Ann Slee, Paula Lorgelly, Munir Pirmohamed, Kamlesh Khunti, Andrew Morris, Cathie Sudlow, Ashley Akbari, Marion Bennie, Naveed Sattar, Reecha Sofat, CVD-COVID-UK Consortium

January 2023

Type

Journal article

Publication

Nature Medicine

Twitter thread summarising key results

💊 Nearly half a million people missed out on starting medication to lower their blood pressure during the #COVID19 pandemic, suggests new research out today in @NatureMedicine led by our Associate Director @ReechaSofat
https://t.co/JFlvaoIqgv pic.twitter.com/po0v0WE3Rw
— The BHF Data Science Centre (@BHFDataScience) January 19, 2023

📰 Selected media coverage

“Covid: Half a million people missed out on heart drugs”. Michelle Roberts, BBC News. 20/01/2023.
“500,000 people ‘missed starting on blood pressure-lowering drugs during Covid’". Nilima Marshall, The Independent. 20/01/2023.
“500,000 people ‘missed starting on blood pressure-lowering drugs during Covid’". Nilima Marshall, The Evening Standard. 20/01/2023.
“Thousands at risk of heart attacks due to Covid disruption, experts warn”. Andrew Gregory, The Guardian. 19/01/2023.

The impact of the COVID-19 pandemic on cardiovascular disease prevention and management

Chris Tomlinson

👨‍💻Health Data Scientist |🎓PhD in AI Healthcare |👨‍⚕️Critical Care Doctor

Related